These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1133 related items for PubMed ID: 18790215

  • 1. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N, Yagisawa T, Sakuma Y, Fujiwara T, Nukui A, Yashi M, Miyamoto N.
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [Abstract] [Full Text] [Related]

  • 2. Kidney transplantation of living unrelated donor-recipient combinations.
    Ishikawa N, Yagisawa T, Sakuma Y, Fujiwara T, Kimura T, Nukui A, Yashi M.
    Transplant Proc; 2012 Jan; 44(1):254-6. PubMed ID: 22310625
    [Abstract] [Full Text] [Related]

  • 3. Preemptive kidney transplantation of living related or unrelated donor-recipient combinations.
    Ishikawa N, Yagisawa T, Sakuma Y, Fujiwara T, Nukui A, Yashi M, Miyamoto N.
    Transplant Proc; 2008 Sep; 40(7):2294-6. PubMed ID: 18790216
    [Abstract] [Full Text] [Related]

  • 4. Kidney transplantation of living unrelated and ABO-incompatible donor-recipient combinations.
    Ishikawa N, Yagisawa T, Kimura T, Sakuma Y, Fujiwara T, Nukui A, Yashi M.
    Transplant Proc; 2013 Apr; 45(3):1242-4. PubMed ID: 23622668
    [Abstract] [Full Text] [Related]

  • 5. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
    Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Toma H.
    Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
    [Abstract] [Full Text] [Related]

  • 6. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Teraoka S, Toma H.
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [Abstract] [Full Text] [Related]

  • 7. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
    Koshino K, Okamoto M, Sakai K, Suzuki T, Nobori S, Matsuyama M, Ushigome H, Okajima H, Yoshimura N.
    Transplant Proc; 2011 Sep; 43(6):2379-82. PubMed ID: 21839272
    [Abstract] [Full Text] [Related]

  • 8. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, Grande JP, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Velosa JA, Textor SC, Platt JL, Stegall MD.
    Transplantation; 2003 Apr 15; 75(7):971-7. PubMed ID: 12698082
    [Abstract] [Full Text] [Related]

  • 9. Improved graft survival in ABO-incompatible living donor kidney transplantation.
    Kaihara S, Okamoto M, Akioka K, Ogino S, Higuchi A, Kadotani Y, Nobori S, Yoshimura N.
    Transplant Proc; 2005 May 15; 37(4):1804-5. PubMed ID: 15919472
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T.
    Contrib Nephrol; 2009 May 15; 162():61-74. PubMed ID: 19001814
    [Abstract] [Full Text] [Related]

  • 11. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K, Saito K.
    Xenotransplantation; 2006 Mar 15; 13(2):118-22. PubMed ID: 16623804
    [Abstract] [Full Text] [Related]

  • 12. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N, Popov Z, Masin-Spasovska J, Dimcevska AH, Kolevski P.
    Xenotransplantation; 2006 Mar 15; 13(2):123-5. PubMed ID: 16623805
    [Abstract] [Full Text] [Related]

  • 13. Japan's experience with living-donor kidney transplantation across ABO barriers.
    Ichimaru N, Takahara S.
    Nat Clin Pract Nephrol; 2008 Dec 15; 4(12):682-92. PubMed ID: 18941430
    [Abstract] [Full Text] [Related]

  • 14. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation.
    Schwartz J, Stegall MD, Kremers WK, Gloor J.
    Transplantation; 2006 Jul 27; 82(2):155-63. PubMed ID: 16858274
    [Abstract] [Full Text] [Related]

  • 15. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later.
    Squifflet JP, De Meyer M, Malaise J, Latinne D, Pirson Y, Alexandre GP.
    Exp Clin Transplant; 2004 Jun 27; 2(1):208-13. PubMed ID: 15859930
    [Abstract] [Full Text] [Related]

  • 16. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
    Takahashi K, Takahara S, Uchida K, Yoshimura N, Toma H, Oshima S, Sonoda T, Japanese Tacrolimus Study Group.
    Transplant Proc; 2005 May 27; 37(4):1800-3. PubMed ID: 15919471
    [Abstract] [Full Text] [Related]

  • 17. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].
    Oppenheimer F, Revuelta I, Serra N, Lozano M, Gutiérrez-Dalmau A, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Crespo M, Paredes D, Martorell J, Alcáraz A, Campistol JM.
    Nefrologia; 2010 May 27; 30(1):54-63. PubMed ID: 20038970
    [Abstract] [Full Text] [Related]

  • 18. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J, Wilpert J, Geyer M, Schwertfeger E, Kirste G, Drognitz O, Walz G, Pisarski P.
    Xenotransplantation; 2006 Mar 27; 13(2):108-10. PubMed ID: 16623802
    [Abstract] [Full Text] [Related]

  • 19. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G, Vidanovic V, Chejfec G, Gangemi A, Iqpal R, Porubsky M, Pham T, Benedetti E.
    Transplantation; 2008 Mar 15; 85(5):681-6. PubMed ID: 18337660
    [Abstract] [Full Text] [Related]

  • 20. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H, Okamoto M, Koshino K, Nobori S, Okajima H, Masuzawa N, Urasaki K, Yoshimura N.
    Clin Transplant; 2010 Jul 15; 24 Suppl 22():16-21. PubMed ID: 20590688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.